๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Mesulergine (CU32-085) in the treatment of Parkinson's disease

โœ Scribed by Dr Ronald F. Pfeifer; Kathleen Wilken; Carolyn Glaeske


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
251 KB
Volume
17
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Viral vectors in the treatment of Parkin
โœ David S. Latchman; Robert S. Coffin ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 88 KB ๐Ÿ‘ 2 views

s disease is an obvious target for the development of gene therapy procedures which could involve both the delivery of the gene encoding tyrosine hydroxylase to boost dopamine production or the delivery of genes encoding neurotrophic factors such as GDNF to promote the survival of dopaminergic neuro